BioRestorative Therapies (NASDAQ:BRTX) versus Hybrid Energy (OTCMKTS:HYBE) Head to Head Analysis

Hybrid Energy (OTCMKTS:HYBE) and BioRestorative Therapies (NASDAQ:BRTX) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, dividends, institutional ownership, risk and earnings.

Profitability

This table compares Hybrid Energy and BioRestorative Therapies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hybrid Energy	N/A	N/A	N/A
BioRestorative Therapies	-2,697.08%	-98.49%	-75.23%

Insider and Institutional Ownership

69.4% of BioRestorative Therapies shares are held by institutional investors. 6.0% of Hybrid Energy shares are held by company insiders. Comparatively, 25.5% of BioRestorative Therapies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Hybrid Energy and BioRestorative Therapies, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hybrid Energy	0	0	0	0	0.00
BioRestorative Therapies	0	0	1	0	3.00

BioRestorative Therapies has a consensus target price of $18.00, indicating a potential upside of 813.71%. Given BioRestorative Therapies’ stronger consensus rating and higher probable upside, analysts plainly believe BioRestorative Therapies is more favorable than Hybrid Energy.

Valuation & Earnings

This table compares Hybrid Energy and BioRestorative Therapies”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hybrid Energy	N/A	N/A	N/A	N/A	N/A
BioRestorative Therapies	$150,000.00	90.88	-$14.41 million	($1.53)	-1.29

Hybrid Energy has higher earnings, but lower revenue than BioRestorative Therapies.

Summary

BioRestorative Therapies beats Hybrid Energy on 6 of the 9 factors compared between the two stocks.

About Hybrid Energy

Hybrid Energy Holdings, Inc., through its subsidiaries, acquires and operates fuel production and other energy companies. It acquires companies with traditional and proven fuel production, photovoltaic (PV) and solar thermal technologies. Hybrid Energy Holdings, Inc. was formerly known as Comprehensive Healthcare Solutions, Inc. and changed its name to Hybrid Energy Holdings, Inc. in September 2009. Hybrid Energy Holdings, Inc. was incorporated in 1966 and is based in Reno, Nevada. Hybrid Energy Holdings, Inc. is in reorganization.

About BioRestorative Therapies

BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. The company was incorporated in 1997 and is based in Melville, New York.